MedTrace Logo

Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis

NCT04354909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-05-16

No results posted yet for this study

Summary

The study aims at defining the role of soluble CD95 Ligand in the physiopathology of the non-infectious uveitis. Soluble CD95 Ligand might have a prognostic interest as well as potential for the discovery of new therapeutic strategies

Conditions

  • Non-Infectious Active Uveitis

Interventions

OTHER

s-CD95-L

levels of s-CD95-L (ELISA test)

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2023-03-10
Completion
2023-03-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04354909 on ClinicalTrials.gov